Open tender · Germany · Contract notice
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-04
Deutsche Rentenversicherung Knappschaft-Bahn-See
Deutsche Rentenversicherung Knappschaft-Bahn-See in Germany is inviting bids for “Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-04”. Bids close on 5 April 2027. To qualify, bidders need at least one similar completed work, Marketing Authorization (Zulassung) and GST registration.
The work
Framework agreement for drug discounts on specified active substances under § 130a SGB V.
- Non-negotiable discount conditions and rates.
- Contract start date is the 1st of the month following receipt of documents, if received by the 5th of the month.
Key facts
- Contract period
- Until 31.05.2027 or earlier termination via formal procurement procedure.
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The tender title is in German and references German law (SGB V, AMG, GWB), not Indian regulations.
- The submission email address and recipient (KBS) are specified, but the exact submission portal or GEM/GepNIC details are not mentioned in the provided text.
Experience
- At least 1 similar work — Not specified; requirement is to be a pharmaceutical company or association per § 4 Abs. 18 AMG.
- Requirement to be a pharmaceutical company or association of pharmaceutical companies as defined by § 4 Abs. 18 Arzneimittelgesetz (AMG).
Certifications and registrations
Marketing Authorization (Zulassung)Required for the active substance(s) as per § 21 Abs. 1 AMG.
GST registrationNot applicable as this is a German tender for pharmaceutical companies under SGB V and AMG.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung über das Vorliegen der Zulassung gemäß § 21 Absatz 1 AMGDeclaration of marketing authorization for the active substance.
- Eigenerklärung zum EU-Sanktionspaket gegen RusslandDeclaration regarding EU sanctions against Russia.
- Eigenerklärung zum Nichtvorliegen von AusschlussgründenDeclaration of no exclusion grounds per §§ 123, 124 GWB.
- Extract from the commercial registerExtract not older than six months, comparable for non-German EU members.